205 related articles for article (PubMed ID: 33190828)
1. Investigation for GSK3β expression in diabetic osteoporosis and negative osteogenic effects of GSK3β on bone marrow mesenchymal stem cells under a high glucose microenvironment.
Chen Y; Chen L; Huang R; Yang W; Chen S; Lin K; Liu J
Biochem Biophys Res Commun; 2021 Jan; 534():727-733. PubMed ID: 33190828
[TBL] [Abstract][Full Text] [Related]
2. miR-124-3p promotes BMSC osteogenesis via suppressing the GSK-3β/β-catenin signaling pathway in diabetic osteoporosis rats.
Li Z; Zhao H; Chu S; Liu X; Qu X; Li J; Liu D; Li H
In Vitro Cell Dev Biol Anim; 2020 Oct; 56(9):723-734. PubMed ID: 33085064
[TBL] [Abstract][Full Text] [Related]
3. GLP-1 promotes osteogenic differentiation of human ADSCs via the Wnt/GSK-3β/β-catenin pathway.
Li Y; Fu H; Wang H; Luo S; Wang L; Chen J; Lu H
Mol Cell Endocrinol; 2020 Sep; 515():110921. PubMed ID: 32615283
[TBL] [Abstract][Full Text] [Related]
4. High-Fat Diet/Low-Dose Streptozotocin-Induced Type 2 Diabetes in Rats Impacts Osteogenesis and Wnt Signaling in Bone Marrow Stromal Cells.
Qian C; Zhu C; Yu W; Jiang X; Zhang F
PLoS One; 2015; 10(8):e0136390. PubMed ID: 26296196
[TBL] [Abstract][Full Text] [Related]
5. Chemerin located in bone marrow promotes osteogenic differentiation and bone formation via Akt/Gsk3β/β-catenin axis in mice.
Li J; Zhang T; Huang C; Xu M; Xie W; Pei Q; Xie X; Wang B; Li X
J Cell Physiol; 2021 Aug; 236(8):6042-6054. PubMed ID: 33492671
[TBL] [Abstract][Full Text] [Related]
6. Connexin 43 Modulates Osteogenic Differentiation of Bone Marrow Stromal Cells Through GSK-3beta/Beta-Catenin Signaling Pathways.
Lin FX; Zheng GZ; Chang B; Chen RC; Zhang QH; Xie P; Xie D; Yu GY; Hu QX; Liu DZ; Du SX; Li XD
Cell Physiol Biochem; 2018; 47(1):161-175. PubMed ID: 29763908
[TBL] [Abstract][Full Text] [Related]
7. Electromagnetic field treatment increases purinergic receptor P2X7 expression and activates its downstream Akt/GSK3β/β-catenin axis in mesenchymal stem cells under osteogenic induction.
Zhang Y; Li W; Liu C; Yan J; Yuan X; Wang W; Wang H; Wu H; Yang Y
Stem Cell Res Ther; 2019 Dec; 10(1):407. PubMed ID: 31864409
[TBL] [Abstract][Full Text] [Related]
8. The Wnt/β-catenin signaling pathway inhibits osteoporosis by regulating the expression of TERT: an in vivo and in vitro study.
Cai Y; Sun H; Song X; Zhao J; Xu D; Liu M
Aging (Albany NY); 2023 Oct; 15(20):11471-11488. PubMed ID: 37862118
[TBL] [Abstract][Full Text] [Related]
9. MFG-E8 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells through GSK3β/β-catenin signaling pathway.
Bai J; Zhang W; Zhou C; Zhao G; Zhong H; Hang K; Xu J; Zhang W; Chen E; Wu J; Liu L; Xue D
FASEB J; 2023 Jun; 37(6):e22950. PubMed ID: 37144883
[TBL] [Abstract][Full Text] [Related]
10. High glucose microenvironments inhibit the proliferation and migration of bone mesenchymal stem cells by activating GSK3β.
Zhang B; Liu N; Shi H; Wu H; Gao Y; He H; Gu B; Liu H
J Bone Miner Metab; 2016 Mar; 34(2):140-50. PubMed ID: 25840567
[TBL] [Abstract][Full Text] [Related]
11. GPR35 regulates osteogenesis via the Wnt/GSK3β/β-catenin signaling pathway.
Zhang Y; Shi T; He Y
Biochem Biophys Res Commun; 2021 Jun; 556():171-178. PubMed ID: 33839412
[TBL] [Abstract][Full Text] [Related]
12. Brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein-1 cooperates with glycogen synthase kinase-3β to regulate osteogenesis of bone-marrow mesenchymal stem cells in type 2 diabetes.
Li X; Liu N; Wang Y; Liu J; Shi H; Qu Z; Du T; Guo B; Gu B
Mol Cell Endocrinol; 2017 Jan; 440():93-105. PubMed ID: 27717746
[TBL] [Abstract][Full Text] [Related]
13. LAMP2A regulates the balance of mesenchymal stem cell adipo-osteogenesis via the Wnt/β-catenin/GSK3β signaling pathway.
Wang Y; Hang K; Ying L; Wu J; Wu X; Zhang W; Li L; Wang Z; Bai J; Gao X; Xue D; Pan Z
J Mol Med (Berl); 2023 Jul; 101(7):783-799. PubMed ID: 37162558
[TBL] [Abstract][Full Text] [Related]
14. The bone marrow-derived mesenchymal stem cells (BMSCs) alleviate diabetic peripheral neuropathy induced by STZ via activating GSK-3β/β-catenin signaling pathway.
He D; Xu Y; Xiong X; Yin C; Lei S; Cheng X
Environ Toxicol Pharmacol; 2020 Oct; 79():103432. PubMed ID: 32502517
[TBL] [Abstract][Full Text] [Related]
15. Methyl-CpG-binding protein 2 promotes osteogenic differentiation of bone marrow mesenchymal stem cells through regulating forkhead box F1/Wnt/β-Catenin axis.
Ji W; Sun X
Bioengineered; 2022 Jan; 13(1):583-592. PubMed ID: 34967263
[TBL] [Abstract][Full Text] [Related]
16. ILK inhibition reduces osteophyte formation through suppression of osteogenesis in BMSCs via Akt/GSK-3β/β-catenin pathway.
Huang Z; Huang L; Ding J; Huang Y; Huang X; Li T
Mol Biol Rep; 2024 Mar; 51(1):421. PubMed ID: 38483756
[TBL] [Abstract][Full Text] [Related]
17. Imperatorin promotes osteogenesis and suppresses osteoclast by activating AKT/GSK3 β/β-catenin pathways.
Yan DY; Tang J; Chen L; Wang B; Weng S; Xie Z; Wu ZY; Shen Z; Bai B; Yang L
J Cell Mol Med; 2020 Feb; 24(3):2330-2341. PubMed ID: 31883297
[TBL] [Abstract][Full Text] [Related]
18. Runx2 alleviates high glucose-suppressed osteogenic differentiation via PI3K/AKT/GSK3β/β-catenin pathway.
Chen Y; Hu Y; Yang L; Zhou J; Tang Y; Zheng L; Qin P
Cell Biol Int; 2017 Aug; 41(8):822-832. PubMed ID: 28462510
[TBL] [Abstract][Full Text] [Related]
19. Diminished membrane recruitment of Akt is instrumental in alcohol-associated osteopenia via the PTEN/Akt/GSK-3β/β-catenin axis.
Chen YX; Zhu DY; Gao J; Xu ZL; Tao SC; Yin WJ; Zhang YL; Gao YS; Zhang CQ
FEBS J; 2019 Mar; 286(6):1101-1119. PubMed ID: 30656849
[TBL] [Abstract][Full Text] [Related]
20. Loss of β-catenin via activated GSK3β causes diabetic retinal neurodegeneration by instigating a vicious cycle of oxidative stress-driven mitochondrial impairment.
Shu XS; Zhu H; Huang X; Yang Y; Wang D; Zhang Y; Zhang W; Ying Y
Aging (Albany NY); 2020 Jun; 12(13):13437-13462. PubMed ID: 32575075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
